Endovascular Engineering (E2) has secured an oversubscribed $42m in a Series B funding round to further its clot removal technology platform, Hēlo PE thrombectomy system, targeting venous ...

Huo said their results may someday be used to change treatment guidelines for stroke survivors who have undergone successful clot removal. “We still need to directly analyze the individual data ...

In this trial, standard care was clot removal without clot-dissolving medication. The added treatment may work by dissolving blood clots in the small vessels (microcirculation) near the major ...

("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology ... solutions for addressing Pulmonary Embolism (PE).

Huo said their results may someday be used to change treatment guidelines for stroke survivors who have undergone successful clot removal. "We still need to directly analyze the individual data of ...